The U.S. Food and Drug Administration (FDA) granted full approval for Pfizer's drug for treating cervical cancer patients ...

Antibody-drug conjugates are a new type of cancer therapy that deliver cancer-killing medicine to cancer cells, avoiding ...

On 18 April 2024, the US Food and Drug Administration (FDA) approved Roche’s Alecensa (alectinib ... all individuals ...

Pfizer Inc. (NYSE: PFE) and Genmab A/S (Nasdaq: GMAB) today announced the U.S. Food and Drug Administration (FDA) approves ...

Patients in South Florida with metastatic melanoma will soon have access to the first cellular therapy for this advanced form ...

The Food and Drug Administration approved Tivdak for metastatic cervical cancer that progressed on or after chemotherapy.

Approval of Tivdak was based on promising results from a Phase III innovaTV 301 clinical trial, which demonstrated a 30% ...

Hercessi marks Accord BioPharma’s first biosimilar to be approved in the United States, with multiple indications for ...

1 “This full approval opens up new treatment paths for this patient community who have long faced limited options," Tamika ...

Much of Moderna’s focus is on nabbing FDA approval for a respiratory syncytial virus vaccine, a decision expected in a matter ...

The approval marks the sixth for a biosimilar referencing Herceptin (trastuzumab) for the treatment of HER2-positive breast ...

The recent FDA approval of Hercessi expands access to a treatment previously burdened by high costs. Hercessi joins the 5 ...